Covid-19-Impfungen: Risiko für Herzmuskelentzündung durch mRNA?

Kolenda KD.: Wie sicher sind die in der EU zugelassenen Covid-19-Impfstoffe Telepolis, 4.1. 2022

Oster ME, et al.: Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. 25.01.2022; Journal of American Medical Association. 2022;327(4):331-340

Oleszak F, et al.: Myocarditis associated with Covid-19. Am J Med Case Rep. 2020;8(12):498-502. doi: 10.12691/ajmcr-8-12-19. Epub 2020 Sep 25

Halsell JS, et al.: Department of Defense Smallpox Vaccination. Clinical Evaluation Team. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. Journal of American Medical Association 2003; 289(24): 3283-3289. doi:10.1001/jama.289.24.3283 ArticlePubMedGoogle ScholarCrossref

Shimabukuro TT, et al.: Safety monitoring in the Vaccine Adverse Event Reporting System (Vaers). Review: Vaccine 26.8.2015; 33(36):4398-405. doi: 10.1016/j.vaccine.2015.07.035. Epub 2015 Jul 22.

Gubernot D, et al.: U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of Covid-19 vaccines. Vaccine 23.6.2021; 39(28):3666-3677. doi: 10.1016/j.vaccine.2021.05.016. Epub 2021 May 14. PMID: 34088506 PMCID: PMC8118666 DOI: 10.1016/j.vaccine.2021.05.016. Free PMC article

Oster ME, et al.: Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. 25.01.2022; Journal of American Medical Association. 2022;327(4):331-340

Kolenda KD.: Impfempfehlung für gesunde Kinder und Jugendliche bleibt fragwürdig. Telepolis, 26.8.2021

Kolenda KD.: Wie wahrscheinlich ist eine Myokarditis nach einer mRNA-Corona-Impfung? Telepolis, 1.10.2021

Quinto CB: To vaccinate, or not to vaccinate…? Schweizer Ärztezeitung 2020; 101 (49): 1637